BAY-794980 (Bayer HealthCare)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBAY-794980 (Bayer HealthCare)

Drug Alias NameNecLip-rFVIIIKogenate FS liposomeKogenate liposomalPEGLip-formulated exogenous FVIII - Bayer/Zilip-PharmaPEGylated octocog alfa sucrose - Bayer/Zilip- Pharma +[7]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor

Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation

TargetsCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRecoly Nv

Active IndicationsN/A

Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A